Talcum Powder Lawsuit Updates
Last updated: August 13, 2026
The Johnson & Johnson talc litigation changed shape in July 2026. After three failed attempts to resolve the ovarian cancer claims through bankruptcy, the company announced a roughly $5.5 billion settlement negotiated in the ordinary tort system instead. This page tracks where that stands, what it covers, and what it does not.
This page is general legal education, not legal advice, and it reports on litigation that is still moving. Nothing here evaluates any individual reader’s claim or creates an attorney-client relationship.
Where the Talc Litigation Stands Now
The federal talc litigation, formally In re: Johnson & Johnson Talcum Powder Products Marketing, Sales Practices and Products Liability Litigation, MDL No. 2738, sits before Judge Michael A. Shipp in the District of New Jersey. Reported case counts put it near 68,900 pending actions in early August 2026, up from roughly 68,000 in June. It has been the largest active MDL in the federal system for some time, and it kept growing through the settlement announcement.
Thousands of additional cases sit in state courts, which matters more here than in most mass torts because the biggest verdicts have come from state juries rather than the MDL. For the underlying allegations see Talcum Powder Ovarian Cancer Lawsuit, and for the asbestos contamination question see Which Talcum Powder Brands Have Faced Asbestos Concerns?
Talc claims are still being filed. A settlement in principle is not the same as a closed docket, and eligibility still turns on diagnosis, product use history, and the deadlines in your state.
Check Whether You May QualifyThe July 2026 Settlement, and What It Covers
In late July 2026, Johnson & Johnson announced an agreement to resolve the ovarian cancer talc claims for a reported $5.5 billion, with a substantial portion scheduled to be paid beginning as early as 2027. Reporting described the deal as covering the large majority of remaining ovarian cancer claims across both state and federal court.
Two features distinguish it from what came before. It was negotiated in the tort system rather than through a bankruptcy of a spun-off subsidiary, after the third such attempt — the Red River Talc filing — was rejected by the bankruptcy court in 2025. And it is reported to require acceptance by a very high percentage of claimants before it becomes final, which means the agreement is not self-executing and individual participation decisions still matter.
What the settlement is reported not to cover is as important as what it does. Mesothelioma claims are on a separate track, and litigation outside the United States is unaffected.
Recent Talc Developments
J&J agreed to pay a reported $5.5 billion to resolve the ovarian cancer claims, subject to a high claimant acceptance threshold. Reporting placed the covered population at roughly 76,000 claims across state and federal court.
The MDL court directed plaintiffs to come forward with evidence of specific causation, following an earlier defense push to dismiss ovarian cancer cases in the MDL. Causation practice continued in parallel with the settlement talks rather than pausing for them.
A Minnesota court declined to disturb a $65.5 million mesothelioma verdict, and a Los Angeles jury returned a $32 million award in a pleural mesothelioma death. In the same period another California jury found for J&J in an ovarian cancer case, and a Los Angeles judge vacated a $950 million punitive award while leaving the compensatory portion in place.
Judge Shipp appointed an experienced mass tort mediator and required both sides to appear with representatives holding full settlement authority. That process ran through the first half of the year and preceded the July announcement.
The bankruptcy court rejected the Red River Talc plan, ending J&J’s third effort to cap talc liability through a subsidiary filing. That ruling returned the entire docket to the tort system and is the reason the 2026 settlement took the form it did.
Why Mesothelioma Claims Are on a Separate Track
Talc litigation has always had two distinct sides. Ovarian cancer claims rest on long-term perineal use of talc products. Mesothelioma claims rest on asbestos contamination of the talc itself, and they are proven much the way any asbestos case is proven — through exposure history, product identification, and pathology.
That difference is why the July settlement is described as an ovarian cancer resolution. Anyone with a mesothelioma diagnosis tied to talc should understand their claim as sitting alongside the wider asbestos litigation rather than inside the ovarian settlement. See Mesothelioma Lawsuit and Asbestos Exposure Lawsuits.
What People Often Watch for Next
- Whether the claimant acceptance threshold is met and the settlement becomes final
- How the allocation and payment schedule is structured for participating claimants
- What happens to claims of anyone who does not participate
- Continued MDL case filings, which had not slowed as of early August 2026
- Rulings on specific causation in the MDL
- State court mesothelioma verdicts, which remain outside the settlement
- Deadlines in individual states, which are unaffected by any settlement
A settlement does not extend a filing deadline. Talc deadlines run on state law and are commonly tied to diagnosis. If a diagnosis is recent, timing is usually the first thing an attorney evaluates.
Start a Free Case ReviewHow This Updates Page Fits With the Main Talc Page
The main Talcum Powder Ovarian Cancer Lawsuit page covers who the litigation involves, what is alleged, and how claims are evaluated. That material changes slowly. This page tracks docket movement and settlement status, which change often. Background on the science sits on Is Talcum Powder Safe? and Which Talcum Powder Brands Have Faced Asbestos Concerns?
Case counts, settlement terms, and court schedules reported here reflect public reporting available on the date above and should be confirmed against the docket before being relied on.
Related Lawsuit Topics
Talcum Powder Ovarian Cancer Lawsuit
The main overview of who is involved and what is alleged.
Is Talcum Powder Safe?
What the research says about talc and cancer risk.
Talcum Powder Brands and Asbestos
Which products have faced asbestos contamination concerns.
Mesothelioma Lawsuit
How mesothelioma claims work, including talc-related ones.
Reproductive Injuries Linked to Lawsuits
Other litigation involving reproductive cancers and conditions.
Mass Torts
How MDLs, bellwethers, and global settlements actually work.
Find Out If You May Have a Case
If you or a family member used talc products long-term and were later diagnosed with ovarian cancer or mesothelioma, a free case review can tell you whether the history fits an available claim path and whether the deadlines in your state still allow it.
Free and no obligation. Lawsuit Center is not a law firm and submitting a request does not create an attorney-client relationship.
